Association Between Longitudinal Change in Abnormal Fasting Blood Glucose Levels and Outcome of COVID-19 Patients Without Previous Diagnosis of Diabetes
- PMID: 33859617
- PMCID: PMC8042381
- DOI: 10.3389/fendo.2021.640529
Association Between Longitudinal Change in Abnormal Fasting Blood Glucose Levels and Outcome of COVID-19 Patients Without Previous Diagnosis of Diabetes
Abstract
This retrospective study examined changes in fasting blood glucose (FBG) levels during hospitalization and their effect on risk of death for Coronavirus disease 2019 (COVID-19) patients without previously diagnosed diabetes. A model with low- and high-stable pattern trajectories was established based on a longitudinal change in FBG levels. We analyzed FBG trajectory-associated clinical features and risk factors for death due to COVID-19. Of the 230 enrolled patients, 44 died and 87.83% had a low-stable pattern (average FBG range: 6.63-7.54 mmol/L), and 12.17% had a high-stable pattern (average FBG range: 12.59-14.02 mmol/L). There were statistical differences in laboratory findings and case fatality between the two FBG patterns. Multivariable logistic regression analysis showed that increased neutrophil count (odds ratio [OR], 25.43; 95% confidence interval [CI]: 2.07, 313.03), elevated direct bilirubin (OR, 5.80; 95%CI: 1.72, 19.58), elevated creatinine (OR, 26.69; 95% CI: 5.82, 122.29), lymphopenia (OR, 8.07; 95% CI: 2.70, 24.14), and high-stable FBG pattern (OR, 8.79; 95% CI: 2.39, 32.29) were independent risk factors for higher case fatality in patients with COVID-19 and hyperglycemia but no history of diabetes. FBG trajectories were significantly associated with death risk in patients with COVID-19 and no diabetes.
Keywords: COVID-19; SARS-CoV-2; fasting blood glucose trajectory; glycemic control; longitudinal change.
Copyright © 2021 Song, Zhang, Wang, Wang, Ma, Ma, Luo, Wang and Jin.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history.Diabetes Res Clin Pract. 2020 Nov;169:108437. doi: 10.1016/j.diabres.2020.108437. Epub 2020 Sep 10. Diabetes Res Clin Pract. 2020. PMID: 32920103 Free PMC article. Clinical Trial.
-
Effect of elevated fasting blood glucose level on the 1-year mortality and sequelae in hospitalized COVID-19 patients: A bidirectional cohort study.J Med Virol. 2022 Jul;94(7):3240-3250. doi: 10.1002/jmv.27737. Epub 2022 Apr 19. J Med Virol. 2022. PMID: 35357022 Free PMC article.
-
[The role of diabetes mellitus as a risk factor of acute myocardial infarction].Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011 Jun;23(6):322-8. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2011. PMID: 21672377 Chinese.
-
High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis.Diabetes Res Clin Pract. 2021 Jan;171:108561. doi: 10.1016/j.diabres.2020.108561. Epub 2020 Dec 9. Diabetes Res Clin Pract. 2021. PMID: 33310127 Free PMC article.
-
COVID-19 in a country with a very high prevalence of diabetes: The impact of admission hyperglycaemia on mortality.Endocrinol Diabetes Metab. 2021 Jun 14;4(3):e00279. doi: 10.1002/edm2.279. eCollection 2021 Jul. Endocrinol Diabetes Metab. 2021. PMID: 34277995 Free PMC article. Review.
Cited by
-
Newly-Diagnosed Diabetes and Sustained Hyperglycemia are Associated with Poorer Outcomes in COVID-19 Inpatients Without Pre-Existing Diabetes.Diabetes Metab Syndr Obes. 2021 Nov 9;14:4469-4482. doi: 10.2147/DMSO.S332819. eCollection 2021. Diabetes Metab Syndr Obes. 2021. PMID: 34795494 Free PMC article.
-
Association of Covid-19 with blood type A in relation to blood sugar, urea, and blood test (D-dimer and ferritin) in patients from Al-Najaf.J Med Life. 2022 Feb;15(2):180-187. doi: 10.25122/jml-2021-0239. J Med Life. 2022. PMID: 35419105 Free PMC article.
-
The Role of Diabetes and Hyperglycemia on COVID-19 Infection Course-A Narrative Review.Front Clin Diabetes Healthc. 2022 Mar 10;3:812134. doi: 10.3389/fcdhc.2022.812134. eCollection 2022. Front Clin Diabetes Healthc. 2022. PMID: 36992740 Free PMC article. Review.
-
Insulin Resistance in Long COVID-19 Syndrome.J Pers Med. 2024 Aug 28;14(9):911. doi: 10.3390/jpm14090911. J Pers Med. 2024. PMID: 39338165 Free PMC article.
References
-
- WHO . Coronavirus disease (COVID-19) pandemic. Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019 (Accessed 2021 February 17).
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous